N-DOSE AD: A Dose Optimization Trial of Nicotinamide Riboside in Alzheimer's Disease

Clinical trial NCT05617508 · COMPLETED

Trial details

NCT number: NCT05617508
Sponsor: Haukeland University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Dementia

Start date: 2022-11-22
Primary completion: 2025-06-05
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.